Supplemental material
Human Vaccines & Immunotherapeutics
Volume 18, 2022 - Issue 6
Pneumococcal – Research Article
Immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults 18 to 64 years old with medical conditions and other factors that increase risk of pneumococcal disease
Charu Sabharwala Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USACorrespondence[email protected]
https://orcid.org/0000-0002-1875-0577View further author information
https://orcid.org/0000-0002-1875-0577View further author information, Vani Sundaraiyerb Biostatistics, Syneos Health, Somerset, NJ, USAhttps://orcid.org/0000-0002-8391-8882View further author information
https://orcid.org/0000-0002-8391-8882View further author information, Yahong Pengc Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USAhttps://orcid.org/0000-0001-5807-3761View further author information
https://orcid.org/0000-0001-5807-3761View further author information, Lisa Moyerc Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USAhttps://orcid.org/0000-0002-6557-8933View further author information
https://orcid.org/0000-0002-6557-8933View further author information, , Bradford D. Gessnerd Vaccines Medical Development and Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USAhttps://orcid.org/0000-0002-6216-7194View further author information
https://orcid.org/0000-0002-6216-7194View further author information, , Kathrin U. Jansena Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USAhttps://orcid.org/0000-0001-5354-4202View further author information
https://orcid.org/0000-0001-5354-4202View further author information, William C. Grubera Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USAhttps://orcid.org/0000-0002-6518-4547View further author information
https://orcid.org/0000-0002-6518-4547View further author information, Daniel A. Scottc Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USAhttps://orcid.org/0000-0002-4916-145XView further author information
https://orcid.org/0000-0002-4916-145XView further author information & Wendy Watsonc Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USAhttps://orcid.org/0000-0002-2858-9000View further author information
https://orcid.org/0000-0002-2858-9000View further author information show all